Factors considered include (1) tumor characteristics, including size, number, vascular invasion, and extrahepatic disease; (2) performative status as defined by the Eastern Cooperative Oncology Group (ECOG) scale; and (3) liver function with a Child–Pugh score calculated by using the lab values for bilirubin, albumin, INR, and the presence of ascites [22]. This evidence concerns the gene ALB and neoplasm.